Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $285.9 million.

  • Collegium Pharmaceutical's Cash & Current Investments rose 13830.46% to $285.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $285.9 million, marking a year-over-year increase of 13830.46%. This contributed to the annual value of $162.8 million for FY2024, which is 4758.85% down from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Cash & Current Investments stood at $285.9 million, which was up 13830.46% from $222.2 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Cash & Current Investments peaked at $325.5 million during Q2 2023, and registered a low of $106.7 million during Q1 2022.
  • Over the past 5 years, Collegium Pharmaceutical's median Cash & Current Investments value was $197.8 million (recorded in 2025), while the average stood at $215.3 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Cash & Current Investments skyrocketed by 16520.92% in 2023 and then crashed by 6061.37% in 2024.
  • Collegium Pharmaceutical's Cash & Current Investments (Quarter) stood at $186.4 million in 2021, then fell by 6.83% to $173.7 million in 2022, then surged by 78.8% to $310.5 million in 2023, then tumbled by 47.59% to $162.8 million in 2024, then surged by 75.63% to $285.9 million in 2025.
  • Its Cash & Current Investments stands at $285.9 million for Q3 2025, versus $222.2 million for Q2 2025 and $197.8 million for Q1 2025.